Biopharmaceutical Analysis & Statistics in North America Countries, February 2011 (p7)

Competitor Analysis Cancer Antibodies in Early Clinical Develoment

$ 1 161
Industry report
February 2011
by La Merie Publishing

Product description The present Competitive Intelligence Report about Cancer Antibodies in Early Clinical Development provides a competitor evaluation in the field of antibody therapeutics being developed ...

Industries : Biopharmaceutical
Countries : United States

Competitor Analysis Erythropoietin (EPO)

$ 645
Industry report
January 2011
by La Merie Publishing

Product description The Competitive Intelligence Report Erythropoietin (EPO) & Erythropoiesis Stimulating Agents (ESA) as of January 2011 in its 5th edition provides information on existing first and second ...

Industries : Biopharmaceutical
Countries : India, World, Mexico, China

Biopharmaceutical Industry: Growth Hormone Deficiency - Pipeline Review, Q4 2010

$ 500
Company report
December 2010
by Global Markets Direct

This report provides data on the therapeutic development for Growth Hormone Deficiency , complete with latest updates, and special features on late-stage and discontinued projects. It also reviews ...

Industries : Biopharmaceutical
Countries : World, United States

Biotechnology Industry 2010 Yearbook - Top Biologics, Biosimilars, Licensing and Financing, Mergers and Acquisitions

$ 3 500
Industry report
December 2010
by GBI Research

Biotechnology Industry 2010 Yearbook - Top Biologics, Biosimilars, Licensing and Financing, Mergers and Acquisitions Summary GBI Research, the leading business intelligence provider, has released its latest ...

Industries : Biopharmaceutical
Countries : World, United States, Japan, Europe

Biopharmaceutical in United States: Micromet, Inc. ? Product Pipeline Review - Q4 2010

$ 500
Company report
December 2010
by Global Markets Direct

- Product Pipeline Review - Q4 2010? provides a detailed overview on the firm ?s research and development focus. The report includes data on current developmental pipeline, complete with latest updates, ...

Industries : Biopharmaceutical
Countries : United States, World

Biopharmaceutical in United States: Inovio Pharmaceuticals, Inc. ? Product Pipeline Review - Q4 2010

$ 500
Company report
December 2010
by Global Markets Direct

- Product Pipeline Review - Q4 2010? provides a detailed overview on the firm ?s research and development focus. The report includes data on current developmental pipeline, complete with latest updates, ...

Industries : Biopharmaceutical
Countries : United States

InNexus Biotechnology Inc. SWOT Analysis, Strategy, Revenues and Profits

$ 125
Company report
December 2010
by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Industries : Biopharmaceutical
Countries : Canada, United States, United Kingdom

U.S. Biopharmaceutical Market - Trends, Forecast, Competition & Strategic Analysis (2009 - 2016)

$ 4 650
Industry report
December 2010
by MarketsandMarkets

Report Description This research report analyzes the U.S. biopharmaceuticals market and its growth factors, with special emphasis on the top companies in the field and their product pipeline. While it ...

Industries : Biopharmaceutical
Countries : United States

ImmunoGen, Inc.: SWOT Analysis & Company Profile

$ 99
Company report
November 2010
by Business Review

Synopsis Business Review's ImmunoGen, Inc. contains a company overview, key facts, locations and subsidiaries, news and events as well as a SWOT analysis of the company. Summary This SWOT Analysis company ...

Industries : Biopharmaceutical
Countries : United States

Antibody Technology Companies 2010 - A systematic guide through the landscape of antibody technologies and their providers

$ 1 284
Industry report
November 2010
by La Merie Publishing

The report ?Antibody Technology Companies 2010 - A systematic guide through the landscape of antibody technologies and their providers? provides a description and assessment of antibody technologies and ...

Industries : Biopharmaceutical, Pharmaceutical, Biotechnology
Countries : United States

Biopharmaceutical: Growth Hormone Deficiency (GHD)

$ 2 000
Company report
November 2010
by Global Data

Industry expert's report, ?Growth Hormone Deficiency - Pipeline Assessment and Industry Projections to 2017?, is an essential source of information and analysis on the global groeth hormone deficiency ...

Industries : Biopharmaceutical
Countries : United States, World, France, Denmark, South Korea, United Kingdom

Quintiles Transnational Corp. SWOT

$ 175
Company report
November 2010
by MarketLine

examines the firm ?s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Quintiles Transnational (Quintiles) is one of the ...

Industries : Biopharmaceutical
Countries : United States

Global Specialty Enzymes Industry

$ 4 500
Industry report
October 2010
by Global Industry Analyst

This report analyzes the worldwide markets for Specialty Enzymes in US$ Million by the following product segments - Specialty Medical Enzymes, Polymerases, Nucleases, and Other Specialty Enzymes. The specific ...

Industries : Biopharmaceutical, Pharmaceutical, Diagnostics, Biotechnology
Countries : World, Japan, Canada, Europe, United States

PDL BioPharma, Inc.: SWOT Analysis & Company Profile

$ 99
Company report
September 2010
by Business Review

Synopsis Business Review's PDL BioPharma, Inc. contains a company overview, key facts, locations and subsidiaries, news and events as well as a SWOT analysis of the company. Summary This SWOT Analysis ...

Industries : Biopharmaceutical
Countries : United States

Nabi Biopharmaceuticals: SWOT Analysis & Company Profile

$ 99
Company report
September 2010
by Business Review

Synopsis Business Review's Nabi Biopharmaceuticals contains a company overview, key facts, locations and subsidiaries, news and events as well as a SWOT analysis of the company. Summary This SWOT Analysis ...

Industries : Biopharmaceutical
Countries : United States

US Enzymes Market

$ 4 900
Industry report
September 2010
by Freedonia

US demand to increase 5.1% annually through 2014 Demand for enzymes in the US is forecast to rise more than five percent annually to $2.7 billion in 2014. Solid industry growth in recent years has been ...

Industries : Biopharmaceutical
Countries : United States

US Enzymes Market: Focus report

$ 600
Industry report
September 2010
by Freedonia

Report Description This report discusses US enzyme demand for the years 2004 and 2009, with forecasts for 2014. Topics covered include market size, product and market segmentation, environmental and regulatory ...

Industries : Biopharmaceutical
Countries : United States

Biopharmaceutical in United States: Celgene Corporation

$ 175
Company report
September 2010
by MarketLine

- SWOT Analysis examines the firm ?s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Celgene, an integrated biopharmaceutical ...

Industries : Biopharmaceutical
Countries : United States

Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies

$ 3 500
Industry report
September 2010
by GBI Research

Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies Summary GBI Research's report, ?Manufacturing ...

Industries : Biopharmaceutical, Biotechnology
Countries : Japan, United States, India, Singapore, China, World, Europe, Asia

Drug Discovery and Development in United States: Millipore Corporation

$ 175
Company report
September 2010
by MarketLine

- SWOT Analysis examines the firm ?s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. (Millipore), a subsidiary of Merck ...

Industries : Biopharmaceutical
Countries : United States

Biopharmaceutical: Symphogen AS

$ 125
Company report
August 2010
by Global Data

Symphogen A/S is a privately-held biopharmaceutical industry player engaged in developing therapeutic polyclonal antibodies (pAb), a new class of biopharmaceuticals, for the treatment of serious human ...

Industries : Biopharmaceutical
Countries : United States

Novel Antibodies & Therapeutic Proteins: Technological Challenges & Future Prospects

$ 1 555
Industry report
August 2010
by Pharmavision

This innovative & analytical report can be used to assess markettrends & appraise the potential of new antibodies & therapeuticproteins. It provides perspective to: gain an in-depth understanding of the ...

Industries : Biopharmaceutical
Countries : United States

Novel Antibodies & Therapeutic Proteins: Technology Challenges & Future Prospects

$ 1 490
Industry report
August 2010
by Pharmavision

This innovative & analytical report can be used to assess markettrends & appraise the potential of new antibodies & therapeuticproteins. It provides perspective to: gain an in-depth understanding of the ...

Industries : Biopharmaceutical, Biological Therapy
Countries : United States

The Funding Landscape for Small Biopharma Ventures, 2010-2015: Trends, strategies and priorities

$ 3 835
Industry report
July 2010
by SCRIP Insights

The funding landscape for small and mid-cap biomedical companies has changed enormously over the past two years, driven by recessive public markets and withdrawal of private equity financing. The cost ...

Industries : Investment Banking, Biopharmaceutical
Countries : United States

Ubiquitin Proteosome Drugs: Cancer and Neurodegenerative Disorder Markets

$ 5 450
Industry report
July 2010
by BCC Research

There is only one approved UPS product on the market, Velcade, a proteasome inhibitor, with total sales of more than $1.4 billion in 2009. This drug is expected to be worth $3 billion in 2015, a compound ...

Industries : Drug Discovery and Development, Drug and Medication, Biopharmaceutical
Countries : World, United States

US Enzyme-Linked Immunosorbent Assay (ELISA) Industry

$ 4 500
Industry report
June 2010
by Global Industry Analyst

This report analyzes the US market for Enzyme-Linked Immunosorbent Assay (ELISA) in US$ Million by the following product segments: ELISA Kits, and ELISA Development Sets and Antibody Pairs. Annual estimates ...

Industries : Biopharmaceutical, Diagnostics
Countries : United States

Whey Proteins Industry

$ 4 500
Industry report
June 2010
by Global Industry Analyst

This report analyzes the US and European Markets for Whey Proteins in US$ Million. The US market is also analyzed by volume (Million Pounds (lbs)). The US market is further analyzed by the following product ...

Industries : Biopharmaceutical, Alternative Medicine, Diet Food
Countries : United States

Competitor Analysis: Streptococcal Vaccines and Antibodies

$ 258
Industry report
June 2010
by La Merie Publishing

Product description The present Competitive Intelligence Report about Streptococcal Vaccines & Antibodies provides a competitor evaluation in the field of prophylactic vaccines and therapeutic antibodies ...

Industries : Biopharmaceutical, Pharmaceutical
Countries : United States

7th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production

$ 845
Industry report
April 2010
by BioPlan Associates, Inc.

This comprehensive look at the state of worldwide biopharmaceutical manufacturing provides the only on-going assessment of manufacturing capacity and production in this $120 billion global industry. You ...

Industries : Biopharmaceutical
Countries : United States, Europe, World

Insmed Incorporated (INSM) SWOT Profile

$ 150
Company report
April 2010
by Global Data

Insmed Incorporated (INSM) SWOT Profile Summary GlobalData's Insmed Incorporated (INSM) SWOT Profile is a comprehensive business, functional and strategic analysis of Insmed Incorporated. The profile delves ...

Industries : Biopharmaceutical, Pharmaceutical, Healthcare
Countries : United States